Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2735]

Potential target for treating many cancers found within GLI1 gene

Potential target for treating many cancers found within GLI1 gene

$FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma$

FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma

Single cell sequencing opens new avenues for eradicating leukaemia at its source

Single cell sequencing opens new avenues for eradicating leukaemia at its source

Study uncovers inhibitory role of 'Ter cells' in cancer therapies

Study uncovers inhibitory role of 'Ter cells' in cancer therapies

Improving immunotherapies for blood cancers: real-time exploration in the tumour

Improving immunotherapies for blood cancers: real-time exploration in the tumour

Targeted delivery of highly toxic anti-cancer drug to brain tumours

Targeted delivery of highly toxic anti-cancer drug to brain tumours

FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression

FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Turbocharging the killing power of immune cells against cancer

Turbocharging the killing power of immune cells against cancer

Unexpected findings on weight loss and breast cancer from international study

Unexpected findings on weight loss and breast cancer from international study

More from ecancer